Evidence map›Paper›PMID 31816633›Full record

ArticleThe Journal of experimental medicine2020

The human fetal thymus generates invariant effector γδ T cells.

Paola Tieppo, Maria Papadopoulou, Deborah Gatti, Naomi McGovern, Jerry K Y Chan, Françoise Gosselin, Glenn Goetgeluk, Karin Weening, Ling Ma, Nicolas Dauby and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 86 citations in OpenAlex.

  1. Article
  2. Article
  3. Oligoclonal expansion of atypical Vδ2Nature communications · 2026
    Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Development of αβ and γδ T Cells in the Thymus and Methods of Analysis.International journal of molecular sciences · 2025
    Review
  11. Article
  12. Review
  13. Review
  14. Development and optimization of Eva1 (Journal for immunotherapy of cancer · 2025
    Article
  15. Review
  16. Article
  17. Regulation of HSC development and function by Lin28b.Frontiers in cell and developmental biology · 2025
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Paola TieppoDepartment of Pharmacotherapy and Pharmaceutics, Université Libre de Bruxelles (ULB), Bruxelles, Belgium.
Maria PapadopoulouDepartment of Pharmacotherapy and Pharmaceutics, Université Libre de Bruxelles (ULB), Bruxelles, Belgium.
Deborah GattiDepartment of Pharmacotherapy and Pharmaceutics, Université Libre de Bruxelles (ULB), Bruxelles, Belgium.
Naomi McGovernDepartment of Pathology and Centre for Trophoblast Research, University of Cambridge, Cambridge, UK.
Jerry K Y ChanDepartment of Reproductive Medicine, KK Women's and Children's Hospital, Singapore.
Françoise GosselinDepartment of Obstetrics and Gynecology, Hôpital Erasme, Université Libre de Bruxelles (ULB), Bruxelles, Belgium.
Glenn GoetgelukDepartment of Clinical Chemistry, Microbiology and Immunology, Ghent University, Ghent, Belgium.
Karin WeeningDepartment of Clinical Chemistry, Microbiology and Immunology, Ghent University, Ghent, Belgium.
Ling MaDepartment of Pharmacotherapy and Pharmaceutics, Université Libre de Bruxelles (ULB), Bruxelles, Belgium.
Nicolas DaubyInstitute for Medical Immunology, Université Libre de Bruxelles (ULB), Gosselies, Belgium.
Alexandra CoganDepartment of Obstetrics and Gynecology, Centre Hospitalier Universitaire Saint-Pierre, Université Libre de Bruxelles (ULB), Bruxelles, Belgium.
Catherine DonnerDepartment of Obstetrics and Gynecology, Hôpital Erasme, Université Libre de Bruxelles (ULB), Bruxelles, Belgium.
Florent GinhouxSingapore Immunology Network, Agency for Science, Technology and Research, Singapore.
Bart VandekerckhoveDepartment of Clinical Chemistry, Microbiology and Immunology, Ghent University, Ghent, Belgium.
David VermijlenDepartment of Pharmacotherapy and Pharmaceutics, Université Libre de Bruxelles (ULB), Bruxelles, Belgium.
Université Libre de Bruxelles · BEGhent University Hospital · BEAgency for Science, Technology and Research · SGNational University of Singapore · SGUniversity of Cambridge · GB

Funding

Wellcome Trust 204464/Z/16/Z
6 · The paper itself

Abstract

In the mouse thymus, invariant γδ T cells are generated at well-defined times during development and acquire effector functions before exiting the thymus. However, whether such thymic programming and age-dependent generation of invariant γδ T cells occur in humans is not known. Here we found that, unlike postnatal γδ thymocytes, human fetal γδ thymocytes were functionally programmed (e.g., IFNγ, granzymes) and expressed low levels of terminal deoxynucleotidyl transferase (TdT). This low level of TdT resulted in a low number of N nucleotide insertions in the complementarity-determining region-3 (CDR3) of their TCR repertoire, allowing the usage of short homology repeats within the germline-encoded VDJ segments to generate invariant/public cytomegalovirus-reactive CDR3 sequences (TRGV8-TRJP1-CATWDTTGWFKIF, TRDV2-TRDD3-CACDTGGY, and TRDV1-TRDD3-CALGELGD). Furthermore, both the generation of invariant TCRs and the intrathymic acquisition of effector functions were due to an intrinsic property of fetal hematopoietic stem and precursor cells (HSPCs) caused by high expression of the RNA-binding protein Lin28b. In conclusion, our data indicate that the human fetal thymus generates, in an HSPC/Lin28b-dependent manner, invariant γδ T cells with programmed effector functions.

Indexed as

Cells, CulturedChildChild, PreschoolDNA NucleotidylexotransferaseFemaleFetusHumansInfantMaleReceptors, Antigen, T-Cell, gamma-deltaRNA-Binding ProteinsThymocytesThymus GlandDNA NucleotidylexotransferaseReceptors, Antigen, T-Cell, gamma-deltaRNA-Binding Proteins

Identifiers

PMID31816633
PMCPMC7062527
OpenAlexW2992851995

What Socratic holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.